Got a new idea?   |   PMR Publications   |   PMR Consulting   |   PMR Research   |   PMR Online Access
 


 

Czech scientists in pursuit of new spinal cord injury treatment


2010-02-09

Scientists at the Institute of Experimental Medicine of the Czech Academy of Science have successfully treated chronic spinal cord injuries in rats and intend to start in vivo clinical trials as soon as possible, according to the CTK news agency. The treatment is based on the insertion of a mixture of hydrogel and stem cells at the location of the spinal cord injury, which stimulates the regeneration of the nervous tissue in the spine.
The Institute intends to start in vivo clinical trials as soon as it has received the appropriate permit, which could take up to one year. The experiment is funded by the French Patients Association, and subjects involved in the trials will come from France and Spain.
During the preclinical study on rats the scientists observed that the mobility and sensitivity of the animals’ hind legs improved within six months. After certain improvements, the treatment could help to cure patients with spinal injuries sustained even a few years beforehand. At present, available treatments which use stem cells are effective only when administered shortly after the injury, but this is not always possible because of the patient’s overall condition.

Browse and search in our archive »


subscribe to PMR RSS NEWS channelsSubscribe to PMR RSS NEWS channels »




PMR publications >> Pharma



Online access:





Central Europe Pharma Online [EN]

1 year subscription to internet service providing market news and analytical articles


Central Europe Pharma Online provides news, articles and market data on the pharmaceutical market in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, from manufacturers and distributors to medical devices and research developments. Over 70 industry updates, covering manufacturers and distributors, medical news and research developments, together with news on laws and regulations governing the pharmaceutical sector are added on a regular basis. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access



description leaflet buy now add to basket request more info




Newsletters:





Central Europe Pharma News [EN]

12-month subscription (26 issues of biweekly news)


Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
Delivery: PDF file



description sample issue buy now add to basket request more info


 
About us         Contact us         Privacy Policy
Copyright © 2012 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.